2026
The Silent Epidemic of Survivorship: Rethinking Cardiovascular Risk in the Era of Targeted and Immune Cancer TherapiesActive, last published 2026
In cancer immunotherapy and biomarkers
Wanjala Micheal
Junior
“Research focused on Cancer Immunotherapy and Biomarkers and adjacent fields.”
Bugema UniversityUganda
Claim Your Profile0
H-index
0
Citations
Wanjala has not officially claimed their profile. If you are Wanjala, claim it free.
Claim Your Profile01 · About the work
What I study
anjala Micheal Junior is a researcher working on Cancer Immunotherapy and Biomarkers. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Wanjala's work has been cited 0 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
05 · Research focus
Topics
Cancer Immunotherapy and Biomarkers×1Chemotherapy-induced cardiotoxicity and mitigation×1Cancer, Stress, Anesthesia, and Immune Response×1
06 · Where I am
Affiliations
CurrentlyBugema University, Uganda
Research themes (UN SDGs)
07 · Selected work
Recent publications
Are you Wanjala?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
No commitment required